Thanks for the response.
Depressing.
Apparently there are docs who will prescribe LDN. Long odds, but
what's to lose?.
http://www.medicalnewstoday.com/medicalnews.php?newsid=24945
http://www.ldninfo.org/
Low LDN Dose Successfully Treats HIV/AIDS, Cancer and MS by
Strengthening Immune System

Main Category: Immune System/Vaccines News
Article Date: 23 May 2005 - 9:00am (UK)

A very low dose of the FDA-approved drug naltrexone has been
discovered to be an effective up-regulator of the immune system. The
new therapy, called low dose naltrexone (LDN), has shown remarkable
effects on an array of illnesses including HIV/AIDS, cancer, and
autoimmune diseases such as MS. The first conference concerning LDN
will be held on June 11th at the New York Academy of Sciences in
Manhattan. Recent clinical trials of LDN will be discussed.

New York, NY (PRWEB) April 18, 2005 -- The drug naltrexone, which in
a 50 mg dose was approved by the FDA many years ago for drug abuse
and for alcoholism, in less than one-tenth that dosage boosts the
immune system and thus helps fight any disease that is characterized
by inadequate immune function.

Investigators mounting successful clinical trials, along with
physicians and patients utilizing low dose naltrexone (LDN), will
make panel presentations on June 11th at a conference to be held at
the New York Academy of Sciences. The keynote speaker will be
Bernard Bihari, MD, a Manhattan physician and the discoverer of the
clinical effects of LDN. This discovery establishes a new paradigm
in medical therapy: LDN not only tends to normalize the immune
system by elevating the body's endorphin levels but also
accomplishes its results with virtually no side effects or toxicity.

Two pilot studies have recently been completed, one for Crohn's
disease and one for multiple sclerosis (MS), and the principal
investigators, respectively from Hershey Medical Center at Penn
State and from Dr. Evers Clinic, a hospital for neurological disease
in Germany, will be present.

The promise of LDN is significant because: (a) it can halt diseases
(e.g., MS and other autoimmune diseases, HIV, and many cancers)
where there are no effective treatment options; (b) it provides
successful treatment while being virtually free of side effects or
toxicity; and (c) were it produced in a developing country, this
generic drug would offer an extremely inexpensive ($10 per year) HIV
treatment, one that does not require close supervision by health
professionals-the patient need only take one small capsule each
night at bedtime.

The conference will be held on June 11, 2005 from 9am to 4pm at the
New York Academy of Sciences, located at 2 East 63rd Street, between
Fifth and Madison Avenues in Manhattan.

For additional information, comprehensive details regarding LDN are
provided at http://www.ldninfo.org. The website
http://www.remedyfind.com includes independent ratings of LDN by
people with MS, who rank it far higher than any other MS medical
treatment; and http://ldners.org/surveys.htm displays results of
surveys of hundreds of people with MS, who are reporting striking
reductions in disease progression as well as marked functional
improvement on LDN alone.

Contact Information:
David Gluck, MD
212-734-5109
http://www.ldninfo.org

N.B.: Interested media representatives should register to attend
this conference as soon as possible in order to assure a reserved
seat.

Hi Michael:
Seems like you have interesting parallels with my sister in law
Cathy.
Low dose naltrexone sounds interesting. The problem maybe that it is
a slow moving treatment, and solid experimental results could take
years?
Please let us know the reactions of your doctors, (and possibly more
importantly, those of the insurance company "diagnosticians" :-) )
I believe Cathy's internist is an AIDS doctor, so it would more than
likely be within his awareness or perhaps even experience. I will
try to get his take.
Any insights from 00doc please?
MikeV